Business Update22 Sept 2026, 01:20 pm
Jenburkt Pharma Shares Permitted to Trade on NSE
AI Summary
Jenburkt Pharmaceuticals Limited has been informed that its equity shares have been admitted to dealings on the Capital Market Segment of the National Stock Exchange of India Limited (NSE) under the "Permitted to Trade" category, effective August 17, 2026. The company clarifies it did not apply for listing on NSE and its shares remain listed on BSE Limited. Jenburkt became aware of this admission through an NSE circular dated August 14, 2026, and is making this disclosure for the information of stakeholders.
Key Highlights
- Jenburkt Pharma shares now "Permitted to Trade" on NSE.
- Listing remains on BSE; no application made to NSE.
- Company learned of admission via NSE circular.
- Disclosure made for stakeholder information.
Price Impact
More from JENBURPH